论文部分内容阅读
目的研究注射用氨溴索与其他药物配伍稳定性。方法采用克林霉素磷酸酯注射液、硫酸头孢噻利、头孢匹胺钠、加替沙星、头孢替唑钠及甲磺酸帕珠沙星等药物与注射用氨溴索联合应用,分析配伍其药物的稳定性。结果注射用氨溴索与其他常用药物配伍未见明显不良反应发生,可有效地改善患者呼吸状况,促使患者的呼吸道分泌正常,降低因分泌物粘稠导致的咳疾等呼吸症状的发生率。结论对慢性支气管炎患者实施注射用氨溴索与其他药物配伍治疗,有效地改善患者的病情,并且患者在治疗期间未出现不良反应及药物副作用,用药安全性较高,值得临床上广泛应用。
Objective To study the compatibility of ambroxol and other drugs for injection. Methods Clindamycin phosphate injection, cefosibir sulfate, cefpiramide sodium, gatifloxacin, ceftezole sodium and pazufloxacin mesylate and other drugs and the combination of ambroxol injection, analysis Compatibility with the stability of the drug. Results Ambroxol injection and other commonly used drug compatibility no obvious adverse reactions occur, which can effectively improve the patient’s respiratory status, promote normal respiratory secretions and reduce the incidence of cough and other respiratory symptoms caused by viscous secretions. Conclusion Ambroxol injection for patients with chronic bronchitis and other drugs compatibility treatment, effectively improve the patient’s condition, and the patient during the treatment did not appear adverse reactions and drug side effects, medication safety is high, it is widely used in clinical.